vimarsana.com

Biocad capable of producing 20 mln doses of Sputnik V a month — CEO

The company is stepping up the production of Sputnik V, because it is aware of its great export potential and believes that it will very likely be approved by the World Health Organization and the European Medicines Agency

Related Keywords

Russia , Dmitry Morozov , Gamaleya Research Center , Eurasian Economic Forum On , European Medicines Agency , World Health Organization , Eurasian Economic Forum ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.